Literature DB >> 19907215

Is maraviroc beneficial in paradoxical progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome management?

Guillaume Martin-Blondel, Lise Cuzin, Pierre Delobel, Victor Cuvinciuc, Hervé Dumas, Muriel Alvarez, Patrice Massip, Bruno Marchou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19907215     DOI： 10.1097/QAD.0b013e32833365f4

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  20 in total

Review 1.  Management of the immune reconstitution inflammatory syndrome.

Authors:  Graeme Meintjes; James Scriven; Suzaan Marais
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

2.  Immune reconstitution disorders in patients with HIV infection: from pathogenesis to prevention and treatment.

Authors:  C C Chang; V Sheikh; I Sereti; M A French
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.071

3.  Not a Disease of the Past: A Case Series of Progressive Multifocal Leukoencephalopathy in the Established Antiretroviral Era.

Authors:  Nathan A Summers; Colleen F Kelley; Wendy Armstrong; Vincent C Marconi; Minh Ly Nguyen
Journal:  AIDS Res Hum Retroviruses       Date:  2019-04-03       Impact factor: 2.205

Review 4.  CCR5 blockade for neuroinflammatory diseases--beyond control of HIV.

Authors:  Guillaume Martin-Blondel; David Brassat; Jan Bauer; Hans Lassmann; Roland S Liblau
Journal:  Nat Rev Neurol       Date:  2016-01-18       Impact factor: 42.937

Review 5.  Progressive multifocal leukoencephalopathy and other forms of JC virus disease.

Authors:  Bruce J Brew; Nicholas W S Davies; Paola Cinque; David B Clifford; Avindra Nath
Journal:  Nat Rev Neurol       Date:  2010-12       Impact factor: 42.937

Review 6.  Pathogenesis and prevention of immune reconstitution disease during antiretroviral therapy.

Authors:  Stephen D Lawn; Graeme Meintjes
Journal:  Expert Rev Anti Infect Ther       Date:  2011-04       Impact factor: 5.091

Review 7.  Opportunistic Neurologic Infections in Patients with Acquired Immunodeficiency Syndrome (AIDS).

Authors:  Fritzie Albarillo; Paul O'Keefe
Journal:  Curr Neurol Neurosci Rep       Date:  2016-01       Impact factor: 5.081

8.  JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene.

Authors:  Shruti P Agnihotri; Xin Dang; Jonathan L Carter; Terry D Fife; Evelyn Bord; Stephanie Batson; Igor J Koralnik
Journal:  Neurology       Date:  2014-07-18       Impact factor: 9.910

9.  A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of a Chemokine Receptor 5 (CCR5) Antagonist to Decrease the Occurrence of Immune Reconstitution Inflammatory Syndrome in HIV-Infection: The CADIRIS Study.

Authors:  Juan G Sierra-Madero; Susan Ellenberg; Mohammed S Rassool; Ann Tierney; Pablo F Belaunzarán-Zamudio; Alondra López-Martínez; Alicia Piñeirúa-Menéndez; Luis J Montaner; Livio Azzoni; César Rivera Benítez; Irini Sereti; Jaime Andrade-Villanueva; Juan L Mosqueda-Gómez; Benigno Rodriguez; Ian Sanne; Michael M Lederman
Journal:  Lancet HIV       Date:  2014-11-01       Impact factor: 12.767

Review 10.  Progressive multifocal leukoencephalopathy therapy.

Authors:  David B Clifford
Journal:  J Neurovirol       Date:  2014-09-17       Impact factor: 2.643
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.